In Myeloid/lymphoid neoplasms with eosinophilia nad rearrangement of PDGFRA, PDGFRB, OR FGFR1, or with PCM1-JAK2 Provisional entity: Myeloid/ lymphoid neoplasms with PCM1-JAK2 In MDS Provisional entity: Refractory cytopenia of childhood In AML and related neoplasms Provisional entity: AML with BCR-ABL1 Provisional entity: AML with mutated RUNX1 In B cell lymphoblastic leukemia Provision entity: B-lymphoblastic leukemia/ lymphoma, BCR-ABL1-like Provision entity: B-lymphoblastic leukemia/ lymphoma with iAMP21 In T cell lymphoblastic leukemia Provisional entity: Early T-cell precursor lymphoblatic leukemia Provisional entity: Natural killer (NK) cell lymphoblastic leukemia/ lymphoma
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.